Other examples include sodium-fluoride PET in breast cancer spinal metastases [15], and fibroblast activation protein (FAP)-targeted radiotracers such as gallium-68 labeled FAP inhibitors ([68 Ga]Ga-FAPI) in bone metastases from lung cancer [54]. This evidence concerns the gene FAP and lung carcinoma.